2nd Symposium on Chemistry for Life Science

Seven individuals, dressed in business attire, stand in front of a large outdoor sign advertising "The 2nd Pharmaron Symposium on Chemistry for Life Science" on March 1st, 2019. The sign, highlighting bioanalytical development and genetic toxicology talks, features photos of keynote speakers. They pose on a grassy area.

Capabilities

Knowledge Center
Symposiums
Synthetic Chemistry
Medicinal Chemistry
Connect with a Scientific Expert

March 1, 2019 l Hoddesdon Site, UK

Pharmaron held its 2nd Symposium: Chemistry for Life Science at its Hoddesdon, UK site. The symposium included six presentations covering the latest updates in drug discovery and synthetic chemistry.

  • Dr. Roland Bürli, Senior Director, Head of Medicinal Chemistry IMED Neuroscience, AstraZeneca, United Kingdom: In Search of New Functions of Arsenic Methyl Transferase
  • Prof. Alois Fürstner, Max-Planck-Institut für Kohlenforschung, Germany: Catalysis in Total Synthesis
  • Dr. Tom Heightman, VP, Medicinal Chemistry & Research Alliances, Astex Therapeutics, United Kingdom: Fragment Based Drug Discovery for Challenging Targets
  • Dr. Emma Parmee, Head of Discovery Chemistry, MSD, United States: New Directions in Drug Discovery at MSD: Expanding Exploration of Chemical Space
  • Prof. Samir Zard, Ecole Polytechnique, France: Radicals in Actions. New Perspectives for Organic Synthesis and Medicinal Chemistry
  • Prof. Yong-Gui Zhou, Dalian Institute of Chemical Physics, China: Asymmetric Hydrogenation of Heteroaromatics